메뉴 건너뛰기




Volumn 156, Issue 6, 1996, Pages 675-677

Erythromycin-induced clozapine toxic reaction

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; ERYTHROMYCIN;

EID: 0030007984     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.6.675     Document Type: Article
Times cited : (60)

References (15)
  • 1
    • 0025599851 scopus 로고
    • Clozapine. a review of its pharmacological properties, and therapeutic use in schizophrenia
    • Fitton A, Heel RC Clozapine. a review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs. 1990,40:722-747.
    • (1990) Drugs , vol.40 , pp. 722-747
    • Fitton, A.1    Heel, R.C.2
  • 2
    • 0026011475 scopus 로고
    • A case report of cimetidine induced clozapine toxicity
    • Szymanski S, Lieberman JA, Picou D, et al. A case report of cimetidine induced clozapine toxicity. J Clin Psychiatry. 1991,52 21-22.
    • (1991) J Clin Psychiatry , vol.52 , pp. 21-22
    • Szymanski, S.1    Lieberman, J.A.2    Picou, D.3
  • 3
    • 0026078295 scopus 로고
    • Effect of phenytoin on plasma clozapine concentrations in two patients
    • Miller DD Effect of phenytoin on plasma clozapine concentrations in two patients. J Clin Psychiatry 1991,52:23-25.
    • (1991) J Clin Psychiatry , vol.52 , pp. 23-25
    • Miller, D.D.1
  • 5
    • 0026766219 scopus 로고
    • Pharmacokinetic drug interactions with macrolide antibiotics
    • Periti P, Mazzei T, Mini E, et al. Pharmacokinetic drug interactions with macrolide antibiotics. Clin Pharmacokinet. 1992;23.106-131.
    • (1992) Clin Pharmacokinet , vol.23 , pp. 106-131
    • Periti, P.1    Mazzei, T.2    Mini, E.3
  • 7
    • 0022497255 scopus 로고
    • Elevated serum theophylline concentration following cessation of erythromycin treatment
    • Wiggins J, Arbab O, Ayres JG, et al Elevated serum theophylline concentration following cessation of erythromycin treatment. Eur J Respir Dis. 1986,68:298-300
    • (1986) Eur J Respir Dis , vol.68 , pp. 298-300
    • Wiggins, J.1    Arbab, O.2    Ayres, J.G.3
  • 8
  • 9
    • 0024566284 scopus 로고
    • Cyclosporin-erythromycin interaction in renal transplant patients
    • Gupta SK, Bakran A, Johnson RW, et al. Cyclosporin-erythromycin interaction in renal transplant patients. Br J Clin Pharmacol. 1989;27: 475-481
    • (1989) Br J Clin Pharmacol , vol.27 , pp. 475-481
    • Gupta, S.K.1    Bakran, A.2    Johnson, R.W.3
  • 10
    • 0027071685 scopus 로고
    • Erythromycin and valproate interaction
    • Redington K, Wells C, Petito F. Erythromycin and valproate interaction. Ann Intern Med. 1992;116: 877-878.
    • (1992) Ann Intern Med , vol.116 , pp. 877-878
    • Redington, K.1    Wells, C.2    Petito, F.3
  • 11
    • 0027469978 scopus 로고
    • Pharmacokinetics and pharmacodynamics of clozapine
    • Jann MW, Grimsley SR, Gray EC, et al. Pharmacokinetics and pharmacodynamics of clozapine Clin Pharmacokinet. 1993;24:161-176.
    • (1993) Clin Pharmacokinet , vol.24 , pp. 161-176
    • Jann, M.W.1    Grimsley, S.R.2    Gray, E.C.3
  • 12
    • 0026666976 scopus 로고
    • The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6
    • Fischer V, Vogels B, Maurer G, et al. The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. J Clin Pharmacol Exp Ther. 1992,260:1355-1360
    • (1992) J Clin Pharmacol Exp Ther , vol.260 , pp. 1355-1360
    • Fischer, V.1    Vogels, B.2    Maurer, G.3
  • 13
    • 0028944753 scopus 로고
    • Metabolism and bioactivation of clozapine by human liver in vitro
    • Pirmohamed M, Williams O, Madden S, et al Metabolism and bioactivation of clozapine by human liver in vitro J Clin Pharmacol Exp Ther. 1995,272:984-990.
    • (1995) J Clin Pharmacol Exp Ther , vol.272 , pp. 984-990
    • Pirmohamed, M.1    Williams, O.2    Madden, S.3
  • 14
    • 0026681168 scopus 로고
    • P450 enzymes: Inhibition mechanisms, genetic regulation and effects of liver disease
    • Murray M. P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet. 1992;23:132-146.
    • (1992) Clin Pharmacokinet , vol.23 , pp. 132-146
    • Murray, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.